| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |